Learn more about Kent State’s Pharmacology Program faculty today. All of our faculty members have extensive educational backgrounds that make them exceptional sources of industry information and insights. Feel free to contact any of the Pharmacology Program faculty listed below by clicking on the link to their email address.
Once you’ve read about the Pharmacology Program faculty members, be sure to learn more about the Pharmacology Program itself. If you have any questions or would like additional information, please contact the School of Biomedical Sciences.
|
David D. Allen
|
Ph.D., University of Kentucky. Nicotine addiction, physiology, pharmacology, treatment, drug delivery. |
|
Sounitra Basu
|
Ph.D., Jefferson University. Molecular basis of RNA structure and function, drug design. More on Basu
|
|
Deepak Bhatia |
Ph,D., genetic and epigenetic changes in human lung cancer, genotoxic stress, growth control genes. More on Bhatia |
|
Richard Carroll
|
Ph.D., University of Toledo. Neurodevelopment, neurodegenerative dieseases, Autism, Alzheimers, inflammation and recovery. More on Carroll |
|
John Y.L. Chiang
|
Ph.D., SUNY Albany. Molecular cloning, expression and regulation of cytochrome P-450 genes; regulation of bile acid synthesis and cholesterol metabolism in the human liver. More on Chiang |
|
Altaf Darvesh |
Ph.D., University of Cincinnati, Development of antioxidant and anti-inflammatory strategies for neoplastic an neurodegenerative diseases, as well as psychiatric disorders. More on Darvesh |
|
Dean E. Dluzen
|
Ph.D., Ill. Inst. Tech. The role of dopamine in corpus striatum as function of age; influence of sex pheromones on neurotransmitter release and in olfactory area. More on Dluzen |
|
Werner J. Geldenhuys
|
Ph.D., North-West University, Potchefstroom. Drug discovery and neurodegenerative disorders, proteomics, bioinformatics. More on Geldenduys |
|
Thomas J. Jones
|
Ph.D., Medical College of Ohio. Cilia mediated heat shock protein suppression, polycystic kidney, signaling pathways. More on Jones |
|
Alexander Mdzinarishvili
|
Ph.D., Russian Academy of Medical Sciences. Metabolic and transmitter changes in stroke. More on Mdzinarishvili |
|
J. Gary Meszaros
|
Ph.D., Univ. Texas Health Sciences Ctr., Houston. G-proteins in cardiac fibroblasts and myocytes; second messengers; receptor desensitization, cardiac fibrosis and failure. More on Meszaros |
|
Priya Raman
|
Ph.D., Northeast Louisiana University. Regulation of thrombospondin-1 by leptin in vascular smooth muscle cells, atherosclerosis. More on Raman |
|
Prabodh Sadana
|
Ph.D., University of Tennessee. Hormonal regulation of lipid metabolism. More on Sadana |
|
Mark A. Simmons
|
Ph.D., Emory University. Neuropharmacology. More on Simmons |
|
Vijay Sutariya E-mail: vsutariya@neomed.edu Phone: 330-325-6485 |
Ph.D., University of Baroda. Drug delivery systems, nanoparticles. More on Sutariya |
|
Charles Thodeti |
Ph.D., S.V. University. Mechanical control of integrin activation in capillary endothelial cells, signal transduction. More on Thodeti |
|
Cornelis J. Van der Schyf
|
D.Sc., Potchefstroom University. etiology of neurodegenerative diseases, pharmaceutical intervention, stroke, Alzheimers, AIDS dementia. More on Van der Schyf |
|
June Yun
|
Ph.D., George Washington University. Signaling via adrenergic receptors, cardiac contractility and growth. More on Yun |
|
Yanqiao Zhang |
Ph.D., Wuhan University. Role FXR in lipid homeostasis and obestiy, atherosclerosis and cholesterol transport. More on Zhang |